Format

Send to

Choose Destination
Nat Rev Nephrol. 2011 Dec 13;8(2):66-8. doi: 10.1038/nrneph.2011.196.

Polycystic kidney disease in 2011: Connecting the dots toward a polycystic kidney disease therapy.

Author information

1
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. torres.vicente@mayo.edu

Abstract

Understanding the complex interactions between the various pathways disrupted in polycystic kidney and liver disease is essential to identify and optimize therapies for these disorders. Studies published in the past year have demonstrated a functional interaction between the main proteins implicated in these diseases and identified novel therapeutic approaches.

PMID:
22158473
PMCID:
PMC4096714
DOI:
10.1038/nrneph.2011.196
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center